Nyxoah SA
XBRU:NYXH

Watchlist Manager

Nyxoah SA

XBRU:NYXH

Watchlist

Dividends

Price: 8.1 EUR 3.58% Market Closed

Market Cap: 278.3m EUR

Have any thoughts about
Nyxoah SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 8.1 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NYXH Alert

Nyxoah SA

8.1

+0.28 (+3.58%)

52 Week Range	3.81 16.8
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Nyxoah SA

What unique competitive advantages
does Nyxoah SA hold over its rivals?

What risks and challenges
does Nyxoah SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Nyxoah SA.

What unique competitive advantages
does Nyxoah SA hold over its rivals?

What risks and challenges
does Nyxoah SA face in the near future?

Has there been any significant insider trading activity
in Nyxoah SA recently?

Summarize the latest earnings call
of Nyxoah SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nyxoah SA.

Provide P/S
for Nyxoah SA.

Provide P/E
for Nyxoah SA.

Provide P/OCF
for Nyxoah SA.

Provide P/FCFE
for Nyxoah SA.

Provide P/B
for Nyxoah SA.

Provide EV/S
for Nyxoah SA.

Provide EV/GP
for Nyxoah SA.

Provide EV/EBITDA
for Nyxoah SA.

Provide EV/EBIT
for Nyxoah SA.

Provide EV/OCF
for Nyxoah SA.

Provide EV/FCFF
for Nyxoah SA.

Provide EV/IC
for Nyxoah SA.

Show me price targets
for Nyxoah SA made by professional analysts.

What are the Revenue projections
for Nyxoah SA?

How accurate were the past Revenue estimates
for Nyxoah SA?

What are the Net Income projections
for Nyxoah SA?

How accurate were the past Net Income estimates
for Nyxoah SA?

What are the EPS projections
for Nyxoah SA?

How accurate were the past EPS estimates
for Nyxoah SA?

What are the EBIT projections
for Nyxoah SA?

How accurate were the past EBIT estimates
for Nyxoah SA?

Compare the revenue forecasts
for Nyxoah SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nyxoah SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nyxoah SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nyxoah SA compared to its peers.

Compare the P/E ratios
of Nyxoah SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Nyxoah SA with its peers.

Analyze the financial leverage
of Nyxoah SA compared to its main competitors.

Show all profitability ratios
for Nyxoah SA.

Provide ROE
for Nyxoah SA.

Provide ROA
for Nyxoah SA.

Provide ROIC
for Nyxoah SA.

Provide ROCE
for Nyxoah SA.

Provide Gross Margin
for Nyxoah SA.

Provide Operating Margin
for Nyxoah SA.

Provide Net Margin
for Nyxoah SA.

Provide FCF Margin
for Nyxoah SA.

Show all solvency ratios
for Nyxoah SA.

Provide D/E Ratio
for Nyxoah SA.

Provide D/A Ratio
for Nyxoah SA.

Provide Interest Coverage Ratio
for Nyxoah SA.

Provide Altman Z-Score Ratio
for Nyxoah SA.

Provide Quick Ratio
for Nyxoah SA.

Provide Current Ratio
for Nyxoah SA.

Provide Cash Ratio
for Nyxoah SA.

What is the historical Revenue growth
over the last 5 years for Nyxoah SA?

What is the historical Net Income growth
over the last 5 years for Nyxoah SA?

What is the current Free Cash Flow
of Nyxoah SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nyxoah SA.

NYXH

Income Statement

Cost of Revenue

Nyxoah SA
Cost of Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Nyxoah SA
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Cost of Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
Nyxoah SA XBRU:NYXH	Cost of Revenue -€1.7m	CAGR 3-Years -281%	CAGR 5-Years N/A	CAGR 10-Years N/A
Biocartis Group NV XBRU:BCART	Cost of Revenue -€29.5m	CAGR 3-Years -11%	CAGR 5-Years -19%	CAGR 10-Years N/A
Ion Beam Applications SA XBRU:IBAB	Cost of Revenue -€294.3m	CAGR 3-Years -19%	CAGR 5-Years -13%	CAGR 10-Years N/A
Sequana Medical NV XBRU:SEQUA	Cost of Revenue -€4.1m	CAGR 3-Years -26%	CAGR 5-Years -27%	CAGR 10-Years N/A

No Stocks Found

Nyxoah SA
Glance View

Market Cap

278.6m EUR

Industry

Health Care

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 72 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Open NYXH Analysis

NYXH Intrinsic Value

3.54 EUR

Overvaluation 56%

Intrinsic Value

Price

What is Intrinsic Value?

What is Nyxoah SA's Cost of Revenue?

Cost of Revenue
-1.7m EUR

Based on the financial report for Dec 31, 2023, Nyxoah SA's Cost of Revenue amounts to -1.7m EUR.

What is Nyxoah SA's Cost of Revenue growth rate?

Cost of Revenue CAGR 3Y
-281%

Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Nyxoah SA have been -281% over the past three years .

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.19 USD 0.54%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	84.15 USD 0.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.94%

	Arista Networks Inc NYSE:ANET	114.65 USD 1.38%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 0.39%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	361.63 USD 0.8%
	ServiceNow Inc NYSE:NOW	1 105.56 USD 1.59%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

Nyxoah SA
XBRU:NYXH

Nyxoah SA
Cost of Revenue

Nyxoah SA
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Nyxoah SA
Glance View

See Also

What is Nyxoah SA's Cost of Revenue?

Cost of Revenue
-1.7m EUR

What is Nyxoah SA's Cost of Revenue growth rate?

Cost of Revenue CAGR 3Y
-281%

Company

Help

Tools

Stocks

Nyxoah SA XBRU:NYXH

Nyxoah SA Cost of Revenue

Nyxoah SA Cost of Revenue Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Nyxoah SA Glance View

See Also

What is Nyxoah SA's Cost of Revenue? Cost of Revenue -1.7m EUR

What is Nyxoah SA's Cost of Revenue growth rate? Cost of Revenue CAGR 3Y -281%

Company

Help

Tools

Stocks

Nyxoah SA
XBRU:NYXH

Nyxoah SA
Cost of Revenue

Nyxoah SA
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Nyxoah SA
Glance View

What is Nyxoah SA's Cost of Revenue?

Cost of Revenue
-1.7m EUR

What is Nyxoah SA's Cost of Revenue growth rate?

Cost of Revenue CAGR 3Y
-281%